An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
Clinical trial NCT01220934 · COMPLETED
Trial details
- NCT number
- NCT01220934
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-04-16
- Primary completion
- 2016-06-01
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.